← back to search

Wei Pei

Guangzhou University of Chinese Medicine · CN
Area of research
Oncology · Surgery
Research interest
Research interests include Medicine, Chemoradiotherapy, Internal medicine, Raltitrexed, Hypertrophic scar, and Apoptosis.
h-index
citations
113
works
6
NIH funding
primary concept
email

Recent publications

Preoperative chemoradiotherapy in older patients with rectal cancer guided by comprehensive geriatric assessment within a multidisciplinary team—a multicenter phase II trial
BMC Geriatrics 2024cited by 5position: middledoi
Preoperative Chemoradiotherapy in Older Patients with Rectal Cancer Guided by Comprehensive Geriatric Assessment within a Multidisciplinary Team—A Multicenter Phase II Trial
Research Square 2023cited by 0position: middledoi
Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis
Genetics Research 2022cited by 10position: middledoi
Safety and efficacy of preoperative chemoradiotherapy in fit older patients with intermediate or locally advanced rectal cancer evaluated by comprehensive geriatric assessment: A planned interim analysis of a multicenter, phase II trial
Journal of Geriatric Oncology 2020cited by 12position: middledoi
<p>Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis</p>
International Journal of Nanomedicine 2019cited by 43position: middledoi
Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib
Medical Science Monitor 2019cited by 42position: lastdoi
Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development
Clinical & Experimental Immunology 2019cited by 29position: middledoi
Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis
Journal of Neuroimmunology 2018cited by 5position: middledoi
Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα
Journal of Neuroinflammation 2016cited by 9position: middledoi
Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer
Medical Oncology 2014cited by 43position: lastdoi
Impact of suppressing retinoic acid-related orphan receptor gamma<i>t</i>(ROR)γt in ameliorating central nervous system autoimmunity
Clinical & Experimental Immunology 2014cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuhong Yang · Fudan University4 papers (2014–2019)Michael K. Racke · Palo Alto University4 papers (2014–2019)Amy E. Lovett‐Racke · Palo Alto University4 papers (2014–2019)Shulian Wang · South China Institute of Collaborative Innovation3 papers (2020–2024)Ning-Ning Lu · Nanjing Medical University3 papers (2020–2024)Yunjie Cheng · Hebei Medical University3 papers (2020–2024)Jian-Wei Liang · Nanjing Medical University3 papers (2020–2024) · 3 papers (2020–2024) · 3 papers (2014–2018)Hui Fang · Shanghai Technical Institute of Electronics & Information3 papers (2020–2024)Yuan Tang · Guangdong University of Technology3 papers (2020–2024)Xishan Wang · Harbin Medical University3 papers (2020–2024)Wenyang Liu · University of Shanghai for Science and Technology3 papers (2020–2024)Haizeng Zhang · Capital Medical University3 papers (2020–2024)Marissa Granitto · Florida State University3 papers (2016–2019)Ye‐Xiong Li · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2020–2024) · 2 papers (2023–2024)Yue Liu · Tongji University2 papers (2016–2018)Jun Wang · Harbin Medical University2 papers (2020–2023)Jing Jin · Sun Yat-sen University Cancer Center2 papers (2023–2024)